A Phase Ib Study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction
Chao, Y., Maglakelidze, M., Bulat, L.V., Yau, T., Tanasanvimon, S., Charoentum, C., Arpornwirat, W., Maneechavakajorn, J., Dechaphunkul, A., Ungtrakul, T., Yen, C.-J., Bai, L.-Y., Chou, W.-C., WeidermVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz422.027
Date:
November, 2019
File:
PDF, 55 KB
2019